Firstly, they are NOT "two large contracts", they are "two large...

Firstly, they are NOT "two large contracts", they are "two large agreements" --- and there's a big difference.

These agreements are not money spinners in themselves, however they serve as a good advertisement for the product and will garner more and more interest for the technology and medical benefits, as well as the fact that patients are reimbursed.

This is a work in progress and is part of the vertical down-up strategy.
The FDA approvals as well as the expected "promotion" of the tech to CAT 1 is the vertical up-down strategy, which is simultaneously being pursued.

Very clever collective strategy IMHO, a strategy that will effectively accelerate SP movement North.